(Q35706837)

9 August 2017

1 reference

title

Immunomodulatory treatment strategies in inflammatory cardiomyopathy: current status and future perspectives (English)

1 reference

9 August 2017

1 reference

Michel Noutsias

1

0 references

Heinz-Peter Schultheiss

series ordinal

4

object named as

Heinz-Peter Schultheiss

1 reference

9 August 2017

Matthias Pauschinger

2

1 reference

9 August 2017

Wolfgang-Christian Poller

series ordinal

3

1 reference

9 August 2017

Uwe Kühl

series ordinal

5

1 reference

9 August 2017

publication date

1 January 2004

1 reference

Expert Review of Cardiovascular Therapy

9 August 2017

published in

1 reference

9 August 2017

volume

2

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

37-51

1 reference

Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

Insights into the pathogenesis of chronic heart failure: immune activation and cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

Progression of familial and non-familial dilated cardiomyopathy: long term follow up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

Long-term outcome of acute myocarditis is independent of cardiac enzyme release

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

Antimyosin scintigraphy and immunohistologic analysis of endomyocardial biopsy in patients with clinically suspected myocarditis--evidence of myocardial cell damage and inflammation in the absence of histologic signs of myocarditis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

Evaluation of viral infection in the myocardium of patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

Molecular diagnosis of myocarditis and dilated cardiomyopathy in children: clinicopathologic features and prognostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

Myocardial inflammatory cell infiltrates in cases of dilated cardiomyopathy as a determinant of outcome following partial left ventriculectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

Highly variable expression of virus receptors in the human cardiovascular system. Implications for cardiotropic viral infections and gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

Expression of coxsackievirus and adenovirus receptor in hearts of rats with experimental autoimmune myocarditis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

Induction of coxsackievirus-adenovirus-receptor expression during myocardial tissue formation and remodeling: identification of a cell-to-cell contact-dependent regulatory mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

Analysis of the coxsackievirus B-adenovirus receptor gene in patients with myocarditis or dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

Low-level expression of a mutant coxsackieviral cDNA induces a myocytopathic effect in culture: an approach to the study of enteroviral persistence in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

HLA class II (DR and DQ) antigen associations in idiopathic dilated cardiomyopathy. Validation study and meta-analysis of published HLA association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

Pathophysiology of viral myocarditis: the role of humoral immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

Signaling pathways for cardiac hypertrophy and failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

Expression of cell adhesion molecules in dilated cardiomyopathy: evidence for endothelial activation in inflammatory cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

Cytotoxic perforin+ and TIA-1+ infiltrates are associated with cell adhesion molecule expression in dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

Parvovirus B19 infection mimicking acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

Collagen degradation in a murine myocarditis model: relevance of matrix metalloproteinase in association with inflammatory induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

Alcoholic cardiomyopathy versus chronic myocarditis--immunohistological investigations with LCA, CD3, CD68 and tenascin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

Adhesion receptors of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

Induction of major histocompatibility complex antigens within the myocardium of patients with active myocarditis: a nonhistologic marker of myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

Inflammatory cardiomyopathy (myocarditis): which patients should be treated with anti-inflammatory therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

Possibility of a new infective aetiological agent in congestive cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

Decreased oxidative stress in patients with idiopathic dilated cardiomyopathy one year after immunoglobulin adsorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

Inhibition of coxsackievirus B3 carrier state infection of cultured human myocardial fibroblasts by ribavirin and human natural interferon-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

Putative mechanisms of the effect of intravenous gamma-globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

sICAM-1 correlates with myocardial ICAM-1 expression in dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

Natalizumab for active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

Antiviral activity of WIN 54954 in coxsackievirus B2 carrier state infected human myocardial fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

Human Coxsackie-Adenovirus Receptor Is Colocalized With Integrins αvβ3and αvβ5on the Cardiomyocyte Sarcolemma and Upregulated in Dilated Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2.1.37

21 January 2018

Identifiers

DOI

10.1586/14779072.2.1.37

1 reference

9 August 2017

1 reference